Empowering Oncology Drug Safety: Leveraging Reproducible Organ-on-a-Chip Models for Hazard Identification
Time: 12:00 pm
day: Day 2
Details:
- Discussing the limitations of current models for assessing immunotoxicity of cell engagers and cell therapies
- The ability of MPS model to mimic human physiological conditions, including cell-cell interactions and microenvironment dynamics, allows for more accurate predictions of drug responses
- Case study: Assessing on-target off-tumor toxicity for T-cell engagers and cell therapy
